Mechanism of misfolding of the human prion protein revealed by a pathological mutation

• Published in: Proceedings of the National Academy of Sciences - PNAS 2021-03, Vol.118 (12), p.1-7
• Main Authors: Sanz-Hernández, Máximo, Barritt, Joseph D., Sobek, Jens, Hornemann, Simone, Aguzzi, Adriano, De Simone, Alfonso
• Format: Article
• Language: English
• Subjects: Amyloid - chemistry; Amyloid - metabolism; Biological Sciences; Humans; Models, Molecular; Mutation; Peptide Fragments - chemistry; Peptide Fragments - metabolism; Prion Diseases - etiology; Prion Diseases - metabolism; Prion Proteins - chemistry; Prion Proteins - genetics; Prions; Protein Aggregation, Pathological - metabolism; Protein Conformation; Protein Folding; Proteostasis Deficiencies; Structure-Activity Relationship
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.2019631118

The misfolding and aggregation of the human prion protein (PrP) is associated with transmissible spongiform encephalopathies (TSEs). Intermediate conformations forming during the conversion of the cellular form of PrP into its pathological scrapie conformation are key drivers of the misfolding process. Here, we analyzed the properties of the C-terminal domain of the human PrP (huPrP) and its T183A variant, which is associated with familial forms of TSEs. We show that the mutation significantly enhances the aggregation propensity of huPrP, such as to uniquely induce amyloid formation under physiological conditions by the sole C-terminal domain of the protein. Using NMR spectroscopy, biophysics, and metadynamics simulations, we identified the structural characteristics of the misfolded intermediate promoting the aggregation of T183A huPrP and the nature of the interactions that prevent this species to be populated in the wild-type protein. In support of these conclusions, POM antibodies targeting the regions that promote PrP misfolding were shown to potently suppress the aggregation of this amyloidogenic mutant.